These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
321 related articles for article (PubMed ID: 24792154)
1. TALENs facilitate targeted genome editing in human cells with high specificity and low cytotoxicity. Mussolino C; Alzubi J; Fine EJ; Morbitzer R; Cradick TJ; Lahaye T; Bao G; Cathomen T Nucleic Acids Res; 2014 Jun; 42(10):6762-73. PubMed ID: 24792154 [TBL] [Abstract][Full Text] [Related]
2. A novel TALE nuclease scaffold enables high genome editing activity in combination with low toxicity. Mussolino C; Morbitzer R; Lütge F; Dannemann N; Lahaye T; Cathomen T Nucleic Acids Res; 2011 Nov; 39(21):9283-93. PubMed ID: 21813459 [TBL] [Abstract][Full Text] [Related]
3. Origins of Programmable Nucleases for Genome Engineering. Chandrasegaran S; Carroll D J Mol Biol; 2016 Feb; 428(5 Pt B):963-89. PubMed ID: 26506267 [TBL] [Abstract][Full Text] [Related]
4. Targeted genome editing by lentiviral protein transduction of zinc-finger and TAL-effector nucleases. Cai Y; Bak RO; Mikkelsen JG Elife; 2014 Apr; 3():e01911. PubMed ID: 24843011 [TBL] [Abstract][Full Text] [Related]
5. TALEN-Mediated Knockout of CCR5 Confers Protection Against Infection of Human Immunodeficiency Virus. Shi B; Li J; Shi X; Jia W; Wen Y; Hu X; Zhuang F; Xi J; Zhang L J Acquir Immune Defic Syndr; 2017 Feb; 74(2):229-241. PubMed ID: 27749600 [TBL] [Abstract][Full Text] [Related]
6. An online bioinformatics tool predicts zinc finger and TALE nuclease off-target cleavage. Fine EJ; Cradick TJ; Zhao CL; Lin Y; Bao G Nucleic Acids Res; 2014 Apr; 42(6):e42. PubMed ID: 24381193 [TBL] [Abstract][Full Text] [Related]
7. Creating designed zinc-finger nucleases with minimal cytotoxicity. Ramalingam S; Kandavelou K; Rajenderan R; Chandrasegaran S J Mol Biol; 2011 Jan; 405(3):630-41. PubMed ID: 21094162 [TBL] [Abstract][Full Text] [Related]
9. The comparison of ZFNs, TALENs, and SpCas9 by GUIDE-seq in HPV-targeted gene therapy. Cui Z; Liu H; Zhang H; Huang Z; Tian R; Li L; Fan W; Chen Y; Chen L; Zhang S; Das BC; Severinov K; Hitzeroth II; Debata PR; Jin Z; Liu J; Huang Z; Xie W; Xie H; Lang B; Ma J; Weng H; Tian X; Hu Z Mol Ther Nucleic Acids; 2021 Dec; 26():1466-1478. PubMed ID: 34938601 [TBL] [Abstract][Full Text] [Related]
10. Broad specificity profiling of TALENs results in engineered nucleases with improved DNA-cleavage specificity. Guilinger JP; Pattanayak V; Reyon D; Tsai SQ; Sander JD; Joung JK; Liu DR Nat Methods; 2014 Apr; 11(4):429-35. PubMed ID: 24531420 [TBL] [Abstract][Full Text] [Related]
11. Expanded activity of dimer nucleases by combining ZFN and TALEN for genome editing. Yan W; Smith C; Cheng L Sci Rep; 2013; 3():2376. PubMed ID: 23921522 [TBL] [Abstract][Full Text] [Related]
12. Cell-penetrating peptide-mediated delivery of TALEN proteins via bioconjugation for genome engineering. Liu J; Gaj T; Patterson JT; Sirk SJ; Barbas CF PLoS One; 2014; 9(1):e85755. PubMed ID: 24465685 [TBL] [Abstract][Full Text] [Related]
13. Stable enhanced green fluorescent protein expression after differentiation and transplantation of reporter human induced pluripotent stem cells generated by AAVS1 transcription activator-like effector nucleases. Luo Y; Liu C; Cerbini T; San H; Lin Y; Chen G; Rao MS; Zou J Stem Cells Transl Med; 2014 Jul; 3(7):821-35. PubMed ID: 24833591 [TBL] [Abstract][Full Text] [Related]
14. Identification of off-target cleavage sites of zinc finger nucleases and TAL effector nucleases using predictive models. Fine EJ; Cradick TJ; Bao G Methods Mol Biol; 2014; 1114():371-83. PubMed ID: 24557916 [TBL] [Abstract][Full Text] [Related]
15. Off-target effects of engineered nucleases. Yee JK FEBS J; 2016 Sep; 283(17):3239-48. PubMed ID: 27208701 [TBL] [Abstract][Full Text] [Related]
16. Genome editing of oncogenes with ZFNs and TALENs: caveats in nuclease design. Shankar S; Sreekumar A; Prasad D; Das AV; Pillai MR Cancer Cell Int; 2018; 18():169. PubMed ID: 30386178 [TBL] [Abstract][Full Text] [Related]
17. In silico abstraction of zinc finger nuclease cleavage profiles reveals an expanded landscape of off-target sites. Sander JD; Ramirez CL; Linder SJ; Pattanayak V; Shoresh N; Ku M; Foden JA; Reyon D; Bernstein BE; Liu DR; Joung JK Nucleic Acids Res; 2013 Oct; 41(19):e181. PubMed ID: 23945932 [TBL] [Abstract][Full Text] [Related]
18. TALEN-mediated functional correction of X-linked chronic granulomatous disease in patient-derived induced pluripotent stem cells. Dreyer AK; Hoffmann D; Lachmann N; Ackermann M; Steinemann D; Timm B; Siler U; Reichenbach J; Grez M; Moritz T; Schambach A; Cathomen T Biomaterials; 2015 Nov; 69():191-200. PubMed ID: 26295532 [TBL] [Abstract][Full Text] [Related]
19. mRNA transfection of a novel TAL effector nuclease (TALEN) facilitates efficient knockout of HIV co-receptor CCR5. Mock U; Machowicz R; Hauber I; Horn S; Abramowski P; Berdien B; Hauber J; Fehse B Nucleic Acids Res; 2015 Jun; 43(11):5560-71. PubMed ID: 25964300 [TBL] [Abstract][Full Text] [Related]
20. Inclusion of homologous DNA in nuclease-mediated gene targeting facilitates a higher incidence of bi-allelically modified cells. Beaton BP; Kwon DN; Choi YJ; Kim JH; Samuel MS; Benne JA; Wells KD; Lee K; Kim JH; Prather RS Xenotransplantation; 2015; 22(5):379-90. PubMed ID: 26381494 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]